U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C12H17NO3
Molecular Weight 223.2683
Optical Activity ( - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUCETIN, (-)-

SMILES

CCOC1=CC=C(NC(=O)CC(C)O)C=C1

InChI

InChIKey=LIAWQASKBFCRNR-UHFFFAOYSA-N
InChI=1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15)

HIDE SMILES / InChI

Molecular Formula C12H17NO3
Molecular Weight 223.2683
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: Description was created based on several sources, including http://www.waters.com/webassets/cms/library/docs/720004141en.pdf | http://www.waters.com/webassets/cms/library/docs/720005475en.pdf | http://journals.sagepub.com/doi/abs/10.1177/009286150103500134

Bucetin (3-hydroxy-p-butyrophenetidide) is an antipyretic analgesic drug with cancerogenic potential. Bucetin was withdrawn from the market due to renal toxicity. The compound has the chiral center. Pharmacological activity of enantiomers is unknown. The racemic mixture is used as a model compound to demostrate effectivity of the chiral supercritical fluid chromatography purification.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Betadid

Approved Use

Unknown
Primary
Betadid

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Drug absorption, metabolism, and excretion. II. Metabolism of bucetin (beta-hydroxybutyro-p-phenetidide) in rabbits.
1968 Sep
Carcinogenicity of bucetin in (C57BL/6 X C3H)F1 mice.
1987 Nov
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The tablet contains bucetin 100 mg, ethoxybenzamide 100 mg, Al-acetylsalicylate 180 mg (https://www.jstage.jst.go.jp/article/cpb1958/15/7/15_7_1002/_pdf)
The tablet contains bucetin 100 mg. The tablets are given to male adults with 200 ml of water on a fasting stomach.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: https://www.jstage.jst.go.jp/article/cpb1958/33/7/33_7_2877/_pdf
Bucetin was found to be mutagenic to Salmonella typhimurum TA100 in the presence of liver 9000g supernatant fraction (S9) prepared from polychlorinated biphenyl (PCB)-treated hamsters and a reduced NADPH-generating system.
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:24:43 UTC 2023
Edited
by admin
on Sat Dec 16 10:24:43 UTC 2023
Record UNII
PLF54F8S2F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUCETIN, (-)-
Common Name English
BUTANAMIDE, N-(4-ETHOXYPHENYL)-3-HYDROXY-, (-)-
Systematic Name English
(-)-BUCETIN
Common Name English
Code System Code Type Description
CAS
156674-10-1
Created by admin on Sat Dec 16 10:24:43 UTC 2023 , Edited by admin on Sat Dec 16 10:24:43 UTC 2023
PRIMARY
FDA UNII
PLF54F8S2F
Created by admin on Sat Dec 16 10:24:43 UTC 2023 , Edited by admin on Sat Dec 16 10:24:43 UTC 2023
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER